NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $215,282 | -3.5% | 2,935 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $223,000 | +8.8% | 2,935 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $205,000 | -93.3% | 2,946 | -78.6% | 0.00% | -90.0% |
| Q2 2021 | $3,048,000 | +67.8% | 13,741 | 0.0% | 0.01% | +66.7% |
| Q1 2021 | $1,816,000 | -23.6% | 13,741 | 0.0% | 0.01% | -33.3% |
| Q4 2020 | $2,378,000 | +259.2% | 13,741 | 0.0% | 0.01% | +80.0% |
| Q1 2019 | $662,000 | +43.9% | 13,741 | 0.0% | 0.01% | +400.0% |
| Q4 2018 | $460,000 | -36.1% | 13,741 | 0.0% | 0.00% | -75.0% |
| Q3 2018 | $720,000 | +67.4% | 13,741 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $430,000 | +43.3% | 13,741 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $300,000 | +7.9% | 13,741 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $278,000 | +1.8% | 13,741 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $273,000 | +14.7% | 13,741 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $238,000 | – | 13,741 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |